BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38346873)

  • 1. Percutaneous microwave ablation on management of hereditary renal cell carcinoma in Von Hippel-Lindau disease.
    Chen J; Zheng L; Zhang W; Wang Z; Yu J; Liang P
    Int J Hyperthermia; 2024; 41(1):2308079. PubMed ID: 38346873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodal image-guided ablation on management of renal cancer in Von-Hippel-Lindau syndrome patients from 2004 to 2021 at a specialist centre: A longitudinal observational study.
    Chan VW; Lenton J; Smith J; Jagdev S; Ralph C; Vasudev N; Bhattarai S; Lewington A; Kimuli M; Cartledge J; Wah TM
    Eur J Surg Oncol; 2022 Mar; 48(3):672-679. PubMed ID: 34728141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repeat Percutaneous Radiofrequency Ablation of T1 Renal Cell Carcinomas is Safe in Patients with Von Hippel-Lindau Disease.
    Wessendorf J; König A; Heers H; Mahnken AH
    Cardiovasc Intervent Radiol; 2021 Dec; 44(12):2022-2025. PubMed ID: 34414496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of renal tumors in Von Hippel-Lindau disease by percutaneous CT fluoroscopic guided radiofrequency ablation: preliminary results.
    Iwamoto Y; Kanda H; Yamakado K; Soga N; Arima K; Takeda K; Sugimura Y
    Fam Cancer; 2011 Sep; 10(3):529-34. PubMed ID: 21503747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous radiofrequency ablation of renal cell carcinomas in patients with von Hippel Lindau disease: indications, techniques, complications, and outcomes.
    Park BK; Kim CK; Park SY; Shen SH
    Acta Radiol; 2013 May; 54(4):418-27. PubMed ID: 23446745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; clinicopathological long-term follow-up.
    Jilg CA; Neumann HP; Gläsker S; Schäfer O; Leiber C; Ardelt PU; Schwardt M; Schultze-Seemann W
    Fam Cancer; 2012 Sep; 11(3):387-94. PubMed ID: 22426863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal tumor size is an independent prognostic factor for overall survival in von Hippel-Lindau disease.
    Kwon T; Jeong IG; Pak S; You D; Song C; Hong JH; Ahn H; Kim CS
    J Cancer Res Clin Oncol; 2014 Jul; 140(7):1171-7. PubMed ID: 24671227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microwave treatment of renal cell carcinoma adjacent to renal sinus.
    Gao Y; Liang P; Yu X; Yu J; Cheng Z; Han Z; Duan S; Huang H
    Eur J Radiol; 2016 Nov; 85(11):2083-2089. PubMed ID: 27776662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications.
    Ierardi AM; Puliti A; Angileri SA; Petrillo M; Duka E; Floridi C; Lecchi M; Carrafiello G
    Med Oncol; 2017 May; 34(5):97. PubMed ID: 28421553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutated Von Hippel-Lindau-renal cell carcinoma (RCC) promotes patients specific natural killer (NK) cytotoxicity.
    Trotta AM; Santagata S; Zanotta S; D'Alterio C; Napolitano M; Rea G; Camerlingo R; Esposito F; Lamantia E; Anniciello A; Botti G; Longo N; Botti G; Pignata S; Perdonà S; Scala S
    J Exp Clin Cancer Res; 2018 Dec; 37(1):297. PubMed ID: 30514329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of renal cell carcinoma in Korean patients with von Hippel-Lindau disease compared to sporadic bilateral or multifocal renal cell carcinoma.
    Kim WT; Ham WS; Ju HJ; Lee JS; Lee JS; Choi YD
    J Korean Med Sci; 2009 Dec; 24(6):1145-9. PubMed ID: 19949673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous radio frequency ablation of renal tumors in patients with von Hippel-Lindau disease: preliminary results.
    Park BK; Kim CK
    J Urol; 2010 May; 183(5):1703-7. PubMed ID: 20299060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor location does not impact oncologic outcomes for percutaneous microwave ablation of clinical T1a renal cell carcinoma.
    Maciolek KA; Abel EJ; Posielski NM; Hinshaw JL; Lubner MG; Lee FT; Ziemlewicz TJ; Wells SA
    Eur Radiol; 2019 Nov; 29(11):6319-6329. PubMed ID: 31016448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probe ablation as salvage therapy for renal tumors in von Hippel-Lindau patients: the Cleveland Clinic experience with 3 years follow-up.
    Yang B; Autorino R; Remer EM; Laydner HK; Hillyer S; Altunrende F; White MA; Khanna R; Stein RJ; Haber GP; O'Malley CM; Kaouk JH
    Urol Oncol; 2013 Jul; 31(5):686-92. PubMed ID: 21723752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Enucleation of renal cell carcinoma in von Hippel-Lindau disease using a microwave tissue coagulator].
    Igarashi T; Sakuma T; Yagasaki H; Igarashi T; Sugimoto S; Hirakata H; Kawata N; Takimoto Y
    Hinyokika Kiyo; 2004 Feb; 50(2):91-3. PubMed ID: 15101163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of renal cell carcinoma in von Hippel-Lindau disease.
    Hes FJ; Slootweg PJ; van Vroonhoven TJ; Hené RJ; Feldberg MA; Zewald RA; Ploos van Amstel JK; Höppener JW; Pearson PL; Lips CJ
    Eur J Clin Invest; 1999 Jan; 29(1):68-75. PubMed ID: 10092992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicenter 10-year oncologic outcome of ultrasound-guided percutaneous microwave ablation of clinical T1 renal cell carcinoma: will it stand the test of time?
    Yu J; Wang H; Cheng ZG; Liu FY; Li QY; He GZ; Luo YC; Yu XL; Han ZY; Liang P
    Eur Radiol; 2022 Jan; 32(1):89-100. PubMed ID: 34195888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk Assessment of Chronic Kidney Disease following Microwave Ablation for Stage T1 Renal Cell Carcinoma.
    Zhou W; Herwald SE; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2018 Dec; 29(12):1685-1691. PubMed ID: 30297311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Tumor Complexity and Technique on Efficacy and Complications after Percutaneous Microwave Ablation of Stage T1a Renal Cell Carcinoma: A Single-Center, Retrospective Study.
    Klapperich ME; Abel EJ; Ziemlewicz TJ; Best S; Lubner MG; Nakada SY; Hinshaw JL; Brace CL; Lee FT; Wells SA
    Radiology; 2017 Jul; 284(1):272-280. PubMed ID: 28076721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.